Executive Director, Investor Relations

Posted 17 Days Ago
Be an Early Applicant
Emeryville, CA
Hybrid
250K-290K Annually
Senior level
Biotech
The Role
The Executive Director of Investor Relations will build relationships with investors, communicate strategy and financial outlook, manage investor communications, and ensure compliance with regulations.
Summary Generated by Built In

Kyverna is recruiting an Executive Director, Investor Relations (IR), in its Corporate Affairs and IR Team, reporting to the Senior Vice President, CA, Communications and IRto lead our investor relations efforts. This role is critical to the business and responsible for building and owning strong relationships with institutional investors, analysts, and key financial stakeholders while ensuring transparent and effective communication takes place regarding the Company’s pipeline progress, market positioning and financial outlook.  The ideal candidate will contribute to our goals of delivering the first autoimmune CAR T therapy to the market while living our core values: bring intellectual humility, elevate each other, and stay true to why

 

Title: Executive Director, Investor Relations

Reports to: SVP, Corporate Affairs, Communications and Investor Relations

Location: Emeryville, CA (Hybrid – twice a week) 

Responsibilities:

  • The Executive Director, Investor Relations (IR), will serve as the primary liaison between investors, analysts, and company leadership, effectively communicating our company strategy, clinical pipeline progress, and financial outlook. Key responsibilities include:
  • Develop and drive an investor relations strategy and tactical IR roadmap aligned with the company’s goals and objectives; establishes the optimal type and mix of shareholders and creates that mix through a variety of targeting initiatives.  
  • Serve as a liaison between the Kyverna leadership team and the investor/analyst community to foster investor confidence and belief in the company's vision and strategy for delivering shareholder value.
  • Cultivate and own long-term relationships with industry analysts and investors, while managing day-to-interactions to drive a consistent and compelling message about the company’s strategy and key operational activities.
  • Own and manage all investor communications including: investor presentations, select press releases, relevant earnings materials, and associated SEC filings to meet disclosure obligations and to ensure accurate and compelling communication.
  • Manage and update company equity story and messaging to support the corporate narrative, in addition to managing a master Q&A document.
  • Monitor market trends, competitor activity, analyst activity and investor sentiment; provide relevant strategic insights and updates to leadership.  Also provide feedback to leadership regarding the investment community’s perception of the company and associated activities, messages, etc.  
  • Prepare senior leaders for meetings with the investment community and provide feedback/post event analysis. 
  • Evaluate and organize investor meetings, biotech conferences, and roadshows to drive strategic engagement.
  • Maintain investor CRM tool to consistently track external interactions.  
  • Manage the IR portion of the Kyverna Web site.   
  • Collaborate across the organization, in particular with R&D, Regulatory and Finance teams to translate scientific and clinical developments into clear investor messaging.
  • Work closely with the Corporate Communications team to align messaging across scientific, regulatory, media, and investor audiences.
  • Ensure compliance with financial and regulatory reporting requirements, including SEC, FDA, and other industry-specific regulations.

Requirements:

  • Bachelor’s or Master’s degree in Finance, Business, Life Sciences, Biotechnology, or a related field.
  • 15+ years of experience in investor relations, finance, or a related role (preferably in a biotech, pharma, or life sciences company).
  • Strong understanding of the healthcare sector including biotech financial models, clinical trial phases, FDA/EMA regulatory processes, and market dynamics.
  • Experience in public company IR and capital markets.
  • Knowledge of SEC disclosure and filing requirements.  
  • Excellent communication skills, with the ability to translate complex scientific data into investor-friendly language.
  • Strong analytical skills for assessing investor sentiment, market trends, and financial performance.
  • Ability to build strong relationships and work effectively and credibly with senior leadership.  
  • Strong personal network of investment community relationships.
  • Strong collaborator; works effectively in teams.
  • Comfortable operating and driving results in a dynamic and highly innovative environment.
  • Detail-oriented, well-organized self-starter; experienced in managing multiple projects simultaneously; flexibility and results-oriented focus are essential.

  • Preferred Qualifications:

  • Experience in public offerings, fundraising, or M&A.
  • CFA, CPA, or CIRO (Certified Investor Relations Officer) is a plus.

The base salary range for candidates residing in the Northern California Area for this position is $250K to $290K annually. This salary range is an estimate of what we reasonably expect to pay for this posted position, and the actual salary may vary based on various factors that may include but are not limited to quality and length of experience, education, geographic location and alignment with market data. 

Top Skills

Capital Markets
Financial Models
Investor Crm Tool
Sec Filing Requirements
Am I A Good Fit?
beta
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.

The Company
HQ: Emeryville, CA
55 Employees
On-site Workplace
Year Founded: 2018

What We Do

Kyverna is a cell therapy company engineering and developing a new class of curative living medicines for inflammatory and autoimmune diseases. Using its SmarTcell™ approach which includes synReg-T cell and synNotch CAR-T technology platforms, Kyverna reprograms T cells to target and selectively suppress or eliminate autoreactive immune cells. The company’s goal is to develop therapies that are selective, potent and durable to tame autoimmunity.

We build interdisciplinary teams that bring a broad range of experiences and scientific expertise together to develop medicines that will free patients from the siege of autoimmune diseases and bring curiosity for exploring and creating the unknown. Our commitment to our employees is to foster an open, supportive, and inclusive environment where we create opportunities for individuals to learn and grow to their full potential at every level.

synNotch is a trademark of Gilead/Kite.

Similar Jobs

Take-Two Interactive Software Logo Take-Two Interactive Software

Senior Analyst, Payroll

Gaming • Information Technology • Mobile • Software
Hybrid
San Mateo, CA, USA
6500 Employees
91K-135K

Notion Logo Notion

Corporate Development

Artificial Intelligence • Productivity • Software
Hybrid
San Francisco, CA, USA
800 Employees
190K-220K
Hybrid
San Francisco, CA, USA
2674 Employees
182K-226K

SoFi Logo SoFi

Business Lead, Deposits

Fintech • Mobile • Software • Financial Services
Easy Apply
Hybrid
4 Locations
4500 Employees

Similar Companies Hiring

SOPHiA GENETICS Thumbnail
Software • Healthtech • Biotech • Big Data • Artificial Intelligence
Boston, MA
450 Employees
Pfizer Thumbnail
Pharmaceutical • Natural Language Processing • Machine Learning • Healthtech • Biotech • Artificial Intelligence
New York, NY
121990 Employees
Takeda Thumbnail
Software • Pharmaceutical • Manufacturing • Healthtech • Biotech • Analytics
Cambridge, MA
50000 Employees

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account